Molecular basis of melanocortin-4 receptor for AGRP inverse agonism

被引:22
作者
Chen, Min [1 ]
Celik, Ahmet [1 ]
Georgeson, Keith E. [1 ]
Hannon, Carroll A. [1 ]
Yang, Yingkui [1 ]
机构
[1] Univ Alabama, Dept Surg, Birmingham, AL 35205 USA
关键词
obesity; AGRP; MC4R; GPCR; inverse agonist;
D O I
10.1016/j.regpep.2006.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have investigated receptor structural components of the melanocortin-4 receptor (MC4R) responsible for ligand-dependent inverse agonism. We utilized agouti-related protein (AGRP), an inverse agonist which reduces MC4R basal cAMP production, as a tool to determine the molecular mechanism. We tested a series of chimeric receptors and utilized MC4R and MC1R as templates, in which AGRP is an inverse agonist for MC4R but not for MC1R. Our results indicate that replacements of the extracellular loops 1, 2 and 3 of MC4R with the corresponding regions of MC1R did not affect AGRP inverse agonist activity. However, replacement of the N terminus of MC4R with the same region of MC1R decreases AGRP inverse agonism. Replacement of transmembrane domains 3, 4, 5 and 6 of MC4R with the corresponding regions of MC1R did not affect AGRP inverse agonist activity but mutation of D90A in transmembrane 2 (TM2) and D298A in TM7 abolished AGRP inverse activity. Deletion of the distal MC4R C terminus fails to maintain AGRP mediated reduction in basal cAMP production although it maintains NDP-MSH mediated cANIP production. In conclusion, our results indicate that the N terminus and the distal C terminus of MC4R do appear to play important roles in AGRP inverse agonism but not NDP-MSH mediated receptor activation. Our results also indicate that the residues D90 in TM2 and D298 in TM7 of hMC4R are involved in not only NDP-MSH mediated receptor activation but also AGRP mediated inverse agonism. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:40 / 49
页数:10
相关论文
共 42 条
[1]  
Alewijnse AE, 1998, J NEUROCHEM, V71, P799
[2]   Constitutive activity of the histamine H1 receptor reveals inverse agonism of histamine H1 receptor antagonists [J].
Bakker, RA ;
Wieland, K ;
Timmerman, H ;
Leurs, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (01) :R5-R7
[3]   NMR structure of a minimized human agouti related protein prepared by total chemical synthesis [J].
Bolin, KA ;
Anderson, DJ ;
Trulson, JA ;
Thompson, DA ;
Wilken, J ;
Kent, SBH ;
Gantz, I ;
Millhauser, GL .
FEBS LETTERS, 1999, 451 (02) :125-131
[4]   Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28 [J].
Casarosa, P ;
Bakker, RA ;
Verzijl, D ;
Navis, M ;
Timmerman, H ;
Leurs, R ;
Smit, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1133-1137
[5]   Inverse agonist activity of agouti and agouti-related protein [J].
Chai, BX ;
Neubig, RR ;
Millhauser, GL ;
Thompson, DA ;
Jackson, PJ ;
Barsh, GS ;
Dickinson, CJ ;
Li, JY ;
Lai, YM ;
Gantz, I .
PEPTIDES, 2003, 24 (04) :603-609
[6]  
Chen G, 2000, MOL PHARMACOL, V57, P125
[7]   Pharmacological properties of 5-hydroxytryptamine4 receptor antagonists on constitutively active wild-type and mutated receptors [J].
Claeysen, S ;
Sebben, M ;
Bécamel, C ;
Eglen, RM ;
Clark, RD ;
Bockaert, J ;
Dumuis, A .
MOLECULAR PHARMACOLOGY, 2000, 58 (01) :136-144
[8]   Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery [J].
de Ligt, RAF ;
Kourounakis, AP ;
Ijzerman, AP .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :1-12
[9]   Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action [J].
Ebihara, K ;
Ogawa, Y ;
Katsuura, G ;
Numata, Y ;
Masuzaki, H ;
Satoh, N ;
Tamaki, M ;
Yoshioka, T ;
Hayase, M ;
Matsuoka, N ;
Aizawa-Abe, M ;
Yoshimasa, Y ;
Nakao, K .
DIABETES, 1999, 48 (10) :2028-2033
[10]   The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis [J].
Ellacott, KLJ ;
Cone, RD .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 59, 2004, 59 :395-408